Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.
about
miR-449 inhibits cell proliferation and is down-regulated in gastric cancerThe Role of Mir-148a in CancerEmerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implicationsMicroRNAs as growth regulators, their function and biomarker status in colorectal cancerNon-coding landscapes of colorectal cancerAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice.Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.Clinical significance of promoter region hypermethylation of microRNA-148a in gastrointestinal cancers.Integrative network analysis reveals active microRNAs and their functions in gastric cancer.MicroRNAs as potential biomarkers for gastric cancer.MiRNA-mediated control of HLA-G expression and function.Inverse association between miR-194 expression and tumor invasion in gastric cancer.microRNA-192, -194 and -215 are frequently downregulated in colorectal cancerMicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism.Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinomaAnalysis of differential miRNA expression in the duodenum of Escherichia coli F18-sensitive and -resistant weaned pigletsThe clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer.MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationThe rescue of miR-148a expression in pancreatic cancer: an inappropriate therapeutic toolmiR-22 represses cancer progression by inducing cellular senescencemiR-148a promoted cell proliferation by targeting p27 in gastric cancer cells.Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer.MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis.Analysis of miRNA expression profiles in breast cancer using biclustering.Clinically relevant microRNAs in ovarian cancerMiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer.MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLCEndometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by EpigeneticsThe 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.RETRACTED: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissuesMicroRNA-148a promotes myogenic differentiation by targeting the ROCK1 gene.Down-regulation of microRNA152 is associated with the diagnosis and prognosis of patients with osteosarcomaThe role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.Novel classes of non-coding RNAs and cancermiRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.TGF-β induces HLA-G expression through inhibiting miR-152 in gastric cancer cells.Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis.
P2860
Q21245766-7281C95D-D9CE-49B2-92D8-BA554113BF5BQ26743549-DC83C7B4-B108-429B-8E08-50AEB6B5AE2DQ26774498-A9904D9A-D253-4749-9A58-F2A669DA72B0Q26775610-FCEBE6B8-22F9-4C0F-A06A-8C6EE443B815Q26778014-2B411345-F535-4784-BA09-4DC841AFF081Q27024427-CEAC4B5E-EB50-4B40-A9FE-503CB5256D11Q33427174-AEDDBC79-0F8E-4E10-87C8-B6347C63ED8AQ33599015-08191401-47C0-4267-94C0-0405FF48A314Q33709601-B90D810C-71FB-40D6-8666-A7A21862C6C4Q33710125-E70E7E36-5305-4101-87D5-89A874142919Q33942494-F14B4627-7229-485B-8217-8C35D026EAD8Q34168445-467BF628-CC1C-485B-ADD2-F1BBB0E74050Q34206215-590BE13C-486B-4F27-BB54-BA04BBB3D7C7Q34208375-D6EDDFCB-CE31-4FD0-A5E0-DFE8E16C24BDQ34299181-7EA4F375-F96D-4B5C-B308-0CB517F43A8BQ34309924-C7CB344F-D2EF-472E-BC75-BFF9D8D096A6Q34365798-A7B6E7D3-A6F2-45CC-A464-868CC0D952ADQ34399366-4EAB7AB4-2337-4DD2-B27C-422FB7995251Q34441849-9DAA02EE-C8A6-4F93-8D87-BE13C391E084Q34506870-95836EFA-52F9-4CC8-BCD8-3CB93BBF8B15Q34576658-532C7139-D3E4-40DC-BC5E-F4DD796B445DQ34825182-3E0174B6-A271-4825-813B-FBA4A5708463Q34941020-47FDA894-0B80-4024-A89D-5382E103BD35Q35034648-056E7213-8DD4-4AAE-8DC9-C42D2CBAE6ACQ35051475-A055F9A3-8E08-49AC-80A7-A0FD157F5861Q35141171-E12A5B2F-377D-43B9-8535-82F0D47618AAQ35204609-67FF2D93-270F-47E2-9AF3-0D8526DB2CA2Q35302023-C24B910F-31A8-41E4-962F-CE38C5CE3254Q35853031-0AEAF316-194D-4024-825B-2E3DB2E3B872Q35865575-14E28424-E00E-4CC7-83B4-0B8E147E581AQ35882785-E4B351B6-DB5D-47C4-9282-7576A36B84C3Q35897271-2732CCF2-9737-4690-B4CC-59EF0905573DQ35926654-88D3EE6F-1BFD-45B6-845D-B25E15AFCFFFQ36033204-2A29A1D2-3546-49E9-BB02-FF047C7DF6AAQ36095261-52684F87-22E0-4081-8759-DFA642F45761Q36158807-D3225231-FD77-4999-B205-2651CB71D65FQ36209417-60F4E445-218B-4E39-AC8E-70A65E6F9520Q36281362-75BC5959-ED8F-49BD-BA63-679D08A508E6Q36340968-EE856B8B-2C3B-40E6-92F8-BB34693AC77FQ36580378-35580F4B-7E60-4FEE-B3CD-51AEDA35EF15
P2860
Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Altered expression of MiR-148a ...... and its clinical significance.
@en
Altered expression of MiR-148a ...... and its clinical significance.
@nl
type
label
Altered expression of MiR-148a ...... and its clinical significance.
@en
Altered expression of MiR-148a ...... and its clinical significance.
@nl
prefLabel
Altered expression of MiR-148a ...... and its clinical significance.
@en
Altered expression of MiR-148a ...... and its clinical significance.
@nl
P2093
P1476
Altered expression of MiR-148a ...... and its clinical significance
@en
P2093
Chengzhong Xing
Huimian Xu
Yongxi Song
Zhenyu Yue
Zhuangkai Liu
P2860
P2888
P304
P356
10.1007/S11605-010-1202-2
P577
2010-04-27T00:00:00Z